- Title
- Multimodality Therapy in Operable Pancreatic Cancer: Should We Sequence Surgery Last?
- Creators
- Jashodeep Datta - Division of Surgical Oncology, Department of Surgery, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USANipun B Merchant - Division of Surgical Oncology, Department of Surgery, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA. nmerchant@med.miami.edu
- Publication Details
- Annals of surgical oncology, Vol.28(4), pp.1884-1886
- Academic Unit
- Miller School of Medicine; UMMG Department of Surgery; UMMG Dept of Surgery - Div of Surgical Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 33454881
- Record Identifier
- 991031599417302976
Journal article
Multimodality Therapy in Operable Pancreatic Cancer: Should We Sequence Surgery Last?
Annals of surgical oncology, Vol.28(4), pp.1884-1886
2021-04
PMID: 33454881
Metrics
6 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.151 Pancreas & Gall Bladder Disorders
- 1.151.395 Pancreatic Cancer
- Web Of Science research areas
- Oncology
- Surgery
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites